Why the Surgical Robot Market is Growing Rapidly in Asia: Considering the Future of Healthcare and the Next Investment Destination
When reading articles about AI or data centers, technology investment can sometimes feel like a story from a distant world.
However, this article focuses on what is happening inside the operating room.
As the medical robot market expands globally, Asia is predicted to see the highest growth.
Why Asia, and why now?
Source:
Summary of this article
The global surgical robot market is expected to expand from $15.98 billion in 2026 to $55.74 billion by 2034
The Asia-Pacific region is projected to have the world's highest growth rate, with an average annual growth of 21%
India is expected to see 18.5% growth, with increasing FDI and new market entrants in the medical field
AI is being utilized for surgical planning and surgical support, accelerating its implementation in medical settings
The training of medical personnel will be a key challenge for future widespread adoption
Article Summary
According to Polaris Market Research, the global surgical robot market is expected to expand from $15.98 billion in 2026 to $55.74 billion by 2034.
The compound annual growth rate is projected at 16.9%, making it one of the most promising growth markets in the medical sector.
Among these, the Asia-Pacific region is expected to see the highest growth.
The region is projected to grow at an average annual rate of 21% until 2034, significantly exceeding the global average.
The background to this includes increased medical investment by various countries, a rise in partnerships between global medical device manufacturers and regional companies, and the introduction of advanced medical technologies.
India, in particular, is projected to have a high growth rate of 18.5% annually.
The increase in foreign direct investment (FDI) in the medical sector and the entry of new medical technology companies are becoming more active, raising its presence as a medical market.
The biggest factor supporting market expansion is the increasing demand for minimally invasive surgery.
Because it reduces the physical burden on patients and is expected to shorten recovery times,
the adoption of robot-assisted surgery is progressing in a wide range of clinical fields, including urology, gynecology, orthopedics, and neurosurgery.
Furthermore, the use of AI technology is also advancing.
AI is being used for preoperative surgical planning, intraoperative instrument control support, and real-time data analysis, supporting improvements in surgical precision and efficiency in medical settings.
Key examples include the launch of new AI-equipped surgical robots and the approval of Intuitive Surgical's latest model, the "da Vinci 5".
On the other hand, specialized training for doctors and medical staff is essential for the widespread adoption of robotic surgery, and a shortage of skilled personnel is pointed out as a significant constraint on future growth. For the market to grow, it is necessary to advance not only the introduction of equipment but also personnel training and the development of medical systems.
From the consultant's perspective (personal opinion)
"It is not just about the growth of the surgical robot market, but that investment in medical advancement is heading toward Asia"—this article makes that point very clear.
In previous articles, we have looked at investments in data centers, submarine cables, logistics hubs, and manufacturing.
This time it is the medical field, but the essence is the same.
Global capital and technology are looking for the next growth market.
And right now, one of the most promising candidates is the Asian medical market.
And here are three implications for today.
1. The next growth market is shifting to Asia
What is interesting about this article is that more than the growth of the market itself, the center of that growth is shifting to Asia.
Surgical robots have been pioneered and popularized in the US and Europe. In fact, it is Western companies like Intuitive Surgical that are currently driving the market.
However, looking at future growth rates, it is Asia that investors and medical device manufacturers are focusing on. The background to this includes the large population size, as well as the development of medical infrastructure, the increase in the middle-income class, and the demand for more sophisticated medical services.
In other words, after the West created the market, the phase of its adoption and expansion is about to begin in Asia.
2. AI is starting to create value in the "medical field" as well
When people think of AI, they tend to focus on chatbots and operational efficiency, but in reality, its application is progressing in fields like medicine.
In this article as well, AI is playing concrete roles such as in surgical planning and intraoperative support.
It was an article that made it easy to recognize once again that the true value of AI lies not in the technology itself, but in how it contributes to decision-making and accuracy in the field.
3. From hardware competition to ecosystem competition
What is interesting is that the shortage of human resources is cited as a challenge.
Simply introducing the robot itself is not enough.
Value is only created once the training of doctors, nurses, and technicians, maintenance systems, and data utilization are in place.
Future competition will likely shift from the robots themselves to who can build a medical ecosystem that can utilize these robots.
When we hear the term surgical robot, it feels like a story from the near future.
However, that future may be quietly beginning not in a laboratory, but in hospital operating rooms.
And perhaps Asia is about to stand at the center of that change.
